As a Senior FAS, with an immunology background and a passion for Sciences, Maxime will present the latest innovations from Cell Signaling Technology (CST). At CST, we are at the forefront of cancer research innovation with SignalStar Multiplex IHC and InTraSeq. SignalStar enables rapid, high-precision spatial biology analysis, generating results in just two days with highly validated antibodies that allow the detection and visualization of up to eight targets in FFPE tissue samples. This technology amplifies the signal of cellular proteins using specific primary antibodies and fluorescent oligonucleotides, providing deep insights into the tumor microenvironment.
Understanding the tumor microenvironment is crucial for developing effective cancer therapies, as it reveals interactions between cancer cells and their surroundings. To further enhance this understanding, InTraSeq offers groundbreaking single-cell analysis, simultaneously detecting RNA and proteins to uncover signaling pathways and molecular mechanisms at single-cell resolution. This technology goes beyond traditional methods, highlighting the dynamics between transcription and translation and quantifying post-translational modifications. These innovations, highly commended by CiteAb, accelerate scientific discovery and empower oncology researchers to develop more effective and personalized cancer therapies.
